NCT07745361
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07745361
Title Study of Oral MRT-2359 With Apalutamide in Prostate Cancer (MODeFIRe-1)
Acronym MODeFIRe-1
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Monte Rosa Therapeutics, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
START Los Angeles RECRUITING Los Angeles California 90025 United States Details
Hoag Memorial Hospital Presbyterian NOT_YET_RECRUITING Newport Beach California 92663 United States Details
Rocky Mountain Cancer Center NOT_YET_RECRUITING Colorado Springs Colorado 80907 United States Details
Kansas University Cancer Center NOT_YET_RECRUITING Kansas City Kansas 66160 United States Details
University of Maryland Greenebaum Cancer Center NOT_YET_RECRUITING Baltimore Maryland 21201 United States Details
Henry Ford NOT_YET_RECRUITING Novi Michigan 48377 United States Details
XCancer Omaha RECRUITING Omaha Nebraska 68130 United States Details
START New Jersey RECRUITING East Brunswick New Jersey 08816 United States Details
Levine Cancer Institute NOT_YET_RECRUITING Charlotte North Carolina 28204 United States Details
Lancaster Urology RECRUITING Lancaster Pennsylvania 17601 United States Details
Sarah Cannon Research Institute NOT_YET_RECRUITING Nashville Tennessee 37203 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
University of Washington Medical Center RECRUITING Seattle Washington 98195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field